BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2024 6:00:26 AM | Browse: 42 | Download: 108
 |
Received |
|
2024-06-12 11:20 |
|
Peer-Review Started |
|
2024-06-12 11:20 |
|
First Decision by Editorial Office Director |
|
2024-09-27 09:43 |
|
Return for Revision |
|
2024-09-27 09:43 |
|
Revised |
|
2024-10-11 04:04 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-11-04 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-04 09:35 |
|
Articles in Press |
|
2024-11-04 09:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-11-12 00:59 |
|
Publish the Manuscript Online |
|
2024-11-19 06:00 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Tongluo Jiedu as an adjuvant therapy for oral cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sarah Monserrat Lomelí Martínez, Melissa Martínez Nieto and Ana Esther Mercado González |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sarah Monserrat Lomelí Martínez, PhD, Department of Medical and Life Sciences, Centro Universitario de la Ciénega, Universidad de Guadalajara, Av. Universidad 1115, Col. Lindavista, Ocotlán 47810, Mexico. sarah.lomeli@academicos.udg.mx |
| Key Words |
Oral cancer, Tongluo Jiedu, Traditional Chinese medicine; Chinese herbal medicine; Herbal drugs; Dentistry |
| Core Tip |
In this letter, we highlight the article by Yin et al recently published in the World Journal of Clinical Cases (2024), which was focused on the benefits of Tongluo Jiedu as an adjuvant treatment for oral cancer. The study showed that this treatment improved immune function and reduced oxidative stress, thereby aiding recovery of the oral cancer patients. We emphasize the need for early intervention, multidisciplinary management, and the potential of integrating traditional Chinese medicine with conventional therapies. |
| Publish Date |
2024-11-19 06:00 |
| Citation |
Lomelí Martínez SM, Martínez Nieto M, Mercado González AE. Tongluo Jiedu as an adjuvant therapy for oral cancer. World J Clin Cases 2025; 13(5): 97909 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i5/97909.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i5.97909 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
